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Intracytoplasmic sperm injection (ICSI) is a successful 
treatment option for severe male infertility, although the 
aetiology of the disorder remains unclear in most cases. 
Recently, microdeletions in the AZF region of the Y 
chromosome have been detected in men with azoospermia 
or severe oligozoospermia. In this study wc investigated 
the prevalence of microdeletions in the AZF region of the
Y chromosome in a population of men undergoing ICSI, 
and looked for clinical characteristics of men with and 
without this deletion. Blood was drawn from 164 men, who 
were on the waiting list for ICSI treatment: 19 were 
azoospermie, 111 oligozoospermie and 34 normozoospermic 
(after previous total fertilization failure). A total of 100 
men with proven fertility served as a control. Microdeletions 
in the AZFc region were present in seven of the 111 
oligozoospermie men (6.3%). Compared with oligozoo­
spermie men without microdeletions, men with micro­
deletions had a lower concentration of follicle stimulating 
hormone (FSH), a lower number of motile spermatozoa 
and a lower frequency of abnormal findings at andrological 
history or examination. No microdeletions were found in 
the azoospermie, normozoospermic and control groups. In 
conclusion, microdeletions in the AZFc region are relatively 
frequently found in men with severe unexplained oligozoo­
spermia. In the ICSI era this finding has an important 
impact because this form of male infertility is now poten­
tially hereditary. Therefore we recommend DNA screening 
(and genetic counselling) before ICSI, especially in men 
with normal FSH, severe oligozoospermia and no abnormal 
clinical andrological findings.
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et a l,  1993). Unfortunately, this rapid development in thera­
peutic possibilities has not been accompanied by a rapid 
increase of knowledge on the aetiology of male infertility. In 
particular, little is known about the contribution of genetic 
factors. Since ICSI circumvents the underlying defects, trans­
mission of genetic factors associated with oligo- or azoospermia 
to the offspring is possible (Bhasin et a l , 1994).
More than two decades ago Tiepolo and Zuffardi (1976) 
reported six azoospermic men with gross deletions of the Y 
chromosome and postulated the existence of a factor, located 
on the Y chromosome, that is necessary for normal spermato­
genesis. Later this factor was named ‘azoospermia factor’ 
(AZF). More recently, small interstitial deletions (microdele­
tions) could be detected by using molecular techniques, and 
several groups found microdeletions of Y qll in azoospermic 
men (Ma et a l , 1992; Reijo et al., 1995; Qureshi et al, 1996; 
Vogt et a l , 1996). Reijo et a l  (1996) and Qureshi et al  (1996) 
showed that these microdeletions are also present on the Y 
chromosome of oligozoospermic men. Although little is known 
on the relationship between the microdeletions and the clinical 
phenotype, the obvious consequence of this observation is that 
some forms of male infertility become hereditary if ICSI 
is used.
We investigated the prevalence of microdeletions in the 
AZF region of the Y chromosome and studied the clinical 
characteristics of men with and without these microdeletions.
Introduction
The introduction of intracytoplasmic sperm injection (ICSI) 
caused a revolution in the treatment of severe male infertility, 
with pregnancy rates up to 35% per cycle (Van Steirteghein
Materials and methods
Annually at our centre, about 200 ICSI treatments are performed. 
There is waiting list of ~1. year. Indications for ICSI are severe 
oligozoospermia (< 1X106 spermatozoa/ml with progressive motility 
per ejaculate), azoospermia (in combination with surgical sperm 
retrieval) and total fertilization failure (TFF) in two previous I VF 
treatments.
At intake, each man was asked for specific andrological problems 
and underwent a thorough andrological examination. Special attention 
was paid to a history of cryptorchidism, male adnexitis, genital 
surgery, sexual function, medication, intoxications and diseases like 
malignancies or colitis. Furthermore, the testis volume was measured 
by a Prader orchidometer and the presence of the vas deferens, 
varicoceles, signs of epididymal obstruction and gynaecomastia were
assessed. The concentrations of follicle stimulating hormone (FSH),
f
luteinizing hormone (LH) and testosterone were measured by commer­
cially available immunoradiometric assays (FSH, LH) and radio­
immunoassay (testosterone) (Medgenix, Fleurus, Belgium). Semen 
analysis was performed according to the guidelines of the World 
Health Organization (WHO, 1992). The first sample was used for 
further analysis. The ‘total number of motile spermatozoa per sample’ 
is the sum of spermatozoa with progressive motility and spermatozoa
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with non-progressive motility (WHO classification a-c). No testis 
biopsies were performed.
In May 1996 we sent a letter to all patients who were on the 
waiting list for ICSI and informed them about the possibility to 
screen for microdeletions on the Y chromosome. In September 1996, 
173 men had responded and had given blood for chromosome and 
DNA analysis (111 oligozoospermic men, 28 azoospermic men and 
34 normozoospermic men after TFF). Nine of the 28 azoospermic 
men had a failed re-anastomosis after previous vasectomy and were 
excluded from further analysis. Men with abnormal test results were 
counselled by a clinical geneticist. It’ microdeletions were found, the 
diagnosis was confirmed in the spermatozoa; the father or brothers 
of the men were asked to give blood for DNA analysis.
To screen for microdeletions in the AZF region of the Y chromo­
some by polymerase chain reaction (PCR), genomic DNA was 
prepared from peripheral blood samples. Each man was analysed for 
the presence of sequence tagged sites (STS) in respectively the AZFa, 
b and c regions (Vogt el ah, 1996) using two different multiplex PCR 
assays. The STS probes used were DYS 148 and DYS 273 (AZFa), 
DYS 218 and DYS 222 (AZFb) (Vogt e t«/., 1996), sY254 and sY255 
(AZFc) and DYS 266 and DYS 242 (control) (Reijo et «/., 1995). 
PCR products were analysed on a 4% agarose gel. We only used 
PCR assays that gave a reliable result in the control sample and we 
did not record u deletion from a patient unless at least two successive 
PCR amplifications of two blood samples taken separately yielded 
negative results. Karyotyping was done using a standard protocol 
(Rooney and C/.epulkowski, 1992).
As a control, the blood of 100 men with proven fertility was 
analysed for the presence of microdeletions. These men were healthy 
family members of patients who counselled the clinical geneticist for 
other reasons. All had one or more children. No semen or hormone 
parameters were available.
The clinical data, semen parameters and hormone measurements 
were coupled to the genetic data. Differences between the clinical 
data of men with and without microdelelkms were statistically tested 
using Student's Mest.
Results
Microdeletions
Microdeletions in the AZFc region were found in seven of the 
111 oligozoospermic men (6.3%) and in none of the 19 
azoospermic men and 34 normozoospermic men. No micro- 
deletions in the AZFa or AZFb regions were found at all. The 
presence of microdeletions in the AZFc region was confirmed 
in the spermatozoa of all seven men. Three men agreed with 
our proposal to screen one of the male family members. One 
father and two brothers were tested and no microdeletions in 
(he AZF region were found, Both brothers had children.
No microdeletions in the AZF region were found in the 100 
fertile men.
Hormones
deletions, we found that the men with the deletion had 
significantly lower FSH and LH than the men without the 
deletion (FSH: 5.6 ±  1.3 IU/1 versus 9.8 ±  0.8 IU/1, P <0.05; 
LH: 3.6 ±  0.3 IU/1 versus 4.9 ±  0.4 IU/1, P <0.05).
Chromosomes
We detected four chromosome abnormalities in the 164 men 
(2.4%); two (1.8%) in the oligozoospermic group: a transloca- 
tion (46,XY, t (4; 16) (q31.1;q22)) and a mosaic Klinefelter 
(46,XY/47,XXY (12/18)), and two (10.5%) in the azoospermic 
group: a Klinefelter (47,XXY) and a mosaic Klinefelter
(46,XY/47,XXY (30/4)).
Semen
The semen parameters of the 164 men are summarized in 
Table IL Concentration and total number o f motile spermatozoa 
per sample in oligozoospermic men with the deletion were 
significantly lower than the concentration and total number of 
motile spermatozoa in oligozoospermic men without the dele­
tion (concentration: 0.5 ±  0 .2X 10r7ml versus 4.3 ±  O.lX iO6/ 
ml, P <0.001; total number of motile spermatozoa: 0.4 ±
0 .2X 106/samplc versus 1.1 ±  0 .2X 106/sample, P <0 ,01). The 
volume of the ejaculate in oligozoospermic and azoospermic 
men was significantly lower than in the normozoospermic men 
(3.5 ±  0.1 ml and 2.8 ±  0.2 ml versus 4.2 ±  0.3 ml; P <0.05).
Andrological history and examination
The results o f the andrological history and physical investi­
gation are summarized in Tables II and III. As expected the 
testis volume of the oligozoospermic and azoospermic men 
was significantly lower than the testis volume in the normozoo­
spermic men (15.2 ±  0.5 ml and 14.8 ±  1.3 ml versus 19.1 
±  0.7 ml; P <0.01).
In nine of the 19 azoospermic men (47%) abnormal androlog­
ical findings were detected; in most cases obstruction was 
present [congenital bilateral absence o f the vas deferens 
(CBAVD)]. In 61 o f the 111 oligozoospermic men (55%) and 
in five of the 34 normozoospermic men (15%) abnormal 
andrological findings were detected.
Looking at the oligozoospermic men with and without 
microdeletions, the frequency of abnormal andrological find­
ings was significantly lower in the men with the deletion as 
compared with the men without the deletion (1/7 versus 
44/104; P <0.05).
Microdeletions in subgroups
As already stated, the prevalence of microdeletions in the 
AZFc region was 7/164 (4.3%) in the whole study group and 
7/111 (6.7%) in the oligozoospermic group. Because of the 
significant differences between the oligozoospermic men with 
and without deletions, we also calculated the prevalence of
The hormonal data of the 164 men are summarized in Table the microdeletions in subgroups. The prevalence in oligozoo-
I. The mean FSH concentrations in oligozoospermic and spermic men with normal FSH (< 1 0  IU/1) was 7/74 (10.3%),
azoospermic men were significantly higher than in normozoo­
spermic men (9.5 ±  0.7 IU/1 and 1.6.8 ±  3.4 IU/l versus 4.6
the prevalence in oligozoospermic men with a very low sperm 
count (total number of motile spermatozoa < 1 X 1 0 6) was
±  0.5 IU/1; P < 0 .0 1). There were no significant differences 6/81 (7.5%) and the prevalence in oligozoospermic men with 
in LH and testosterone concentrations between the three no specific findings at andrological history was 6/58 (10.3%). 
groups. Looking at the oligozoospermic men with and without There were 25 oligozoospermic men who complied with all
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Table I. Hormonal data of 164 men undergoing intracytoplasmic sperm injection (mean ±  SE)
n FSH (IU/Ì) LH (IU/1) Testosterone
Oligozoospermia 111 9.5 ±  0.7* 4.8 ±  0.4 17 ±  0.6
with deletion 7 5.6 ±  1.3 ** 3,6 ±  0.3** 16.2 ±  1,7
without deletion 104 9.8 ±  0.8 4.9 ±  0.4 18.0 ±  0.7
Azoospermia 19 16.8 ±  3.4* 5.2 ±  0.1 19.2 ±  1.3
Normozoospermia 34 4.6 ± 0.5 3.6 ±  0.3 17.8 ±  0.2
^Significantly higher than in normozoospermic men (P <0.01).
**Significantly lower than in oligozoospermie men without the deletion (P <0.05) 
FSH = follicle stimulating hormone; LH = luteinizing hormone.
Table II. Semen parameters and testis volume of 164 men undergoing intracytoplasmic sperm injection (mean ±  SE)
n Volume
(ml)
pH
4
Concentration 
(X 106/ml)
Motility
(%)a
Total no. motile sperm 
cells per sample (X l06)a
Morphology 
(% abnormal)
Testis volume 
(mi)
Oligozoospermia 111 3.5 ±  0.1** 7,7 ±  0.1 4.1 ±  1.0 15.7 ±  1,6 1.1 ±  0.2 64.5 ±  1.5 15.2 ±  0.5*’*
with deletion 7 3,9 ±  0.9 7.7 ±  0.1 0.5 ±  0.2* 13.9 ±  5.7 0.4 ±  0.2* 86,5 ±  6.5 15.6 ± 2.0
without deletion 104 3.5 ±  0.2 7.7 ±  0.1 4.3 ±  0.1 15.8 ±  1.7 1.1 ±  0.2 63.8 ± 1.5 15.2 ±  0.5
Azoospermia 19 2.8 ±  0.2** 7.6 ± 0 .1 0 — 0 — 14.8 t  1.3**
Normospennia 34 4.2 ±  0.3 7.8 ±  0.1 25.0 ±  3,6 32.8 ±  2.5 36.2 ±  7.4 56.1 ±  2.8 19.1 ± 0.7
“Including rapid linear progression, slow or non-linear progression and non-progressive motility (WHO classification a, b and c) 
^'Significantly lower than in oligozoospermie men without the deletion (P <0.001),
‘^ 'Significantly lower than in normozoospermic men (P <0.05).
Table III. Summary of findings during andrological history and examination in 164 men undergoing intracytoplasmic sperm injection
n Cryptorchism Inguinal
hernia
Varicocele CBAVD Torsion
testis
Male
adnexitis
Ejaculation Radio­
problems therapy
Miscellaneous* No
findings
Oligozoospermia 111 21 7 17 1 6 4 3 7 50
with deletion 7 — — 1 — — — — — 6
without deletion 104 21 7 16 — 1 6 4 3 7 44
Azoospermia 19 1 — — 4 1 — 1 2 — 10
Normospennia 34 — 2 4
i
***** 1 — — — 29
CBAVD ~  congenital bilateral absence of the vas deferens.
^Including gynaecomastia (n =  1), lymph oedema (// =  1), colitis without medication (n — 2), intrauterine DES exposition (n =  3).
Discussion
these three criteria and five of them had the microdeletion The DAZ gene is equivalent to AZFc, as has been suggested 
(20%). by Vogt et a i  (1996). They proposed in their recent paper the
presence of three spermatogenesis loci in Yql l and designated 
them as AZFa, AZFb and AZFc.
Recently, Reijo et a l  (1996) showed that microdeletions in 
The studies regarding the relationship between male infertility the AZF region are not limited to azoospermic men, but may
and Y deletions started with the publication of Tiepolo and ajso be detected in men with severe oligozoospermia. They
Zuffardi in 1976. They found gross deletions in azoospermic found microdeletions in two out of 35 men (6%) who presented
men and postulated the existence of a factor located on the with severe oligozoospermia. We also found microdeletions in
long arm of the Y chromosome, later named AZF. Two oligozoospermic men and therefore the names AZF (azoo-
‘candidate’ genes for AZF have been suggested; RBM (RNA spermia factor) and DAZ (deleted in azoospermia) are no
binding motif) by the group of Chandley (Ma et a l , 1992) longer correct.
and DAZ (deleted in azoospermia) by the group of Page (Reijo The prevalence of microdeletions in infertile men ranges in
et a l , 1995). Both genes are expressed in testis and encode a the literature from 3% (12/370; Vogt et a l,  1996), 8% (8/100;
presumed RNA-binding protein of which the precise function Qureshi et a l , 1996), 9% (11/117; Hargreave et a l , 1996),
remains to be determined. RBM (initially labelled YRRM; Y 13% (12/89; Reijo et a l , 1995) to 19% (10/53; Kobayashi
located RNA recognition motif) seems to be a gene family e ta l ,  1994). There are several problems with the interpretation
and multiple copies are distributed along the Y chromosome. of these figures. Firstly, the study groups are not the same
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since the inclusion criteria differ from oligozoospermia (Reijo percentage of male infertility due to genetic defects is even
et a l 1996), azoospermia (Kobayashi et a l , 1994) or both higher. Firstly, we did not screen the complete Y chromosome
(Reijo et a l , 1995; Hargreave et a l , 1996; Qureshi et a l , for the presence of microdeletions. Secondly, by performing
1996; Vogt et a l , 1996). Secondly, different regions (RBM, PCR analysis, mosaicism of microdeletions could be missed.
DAZ, AZFa, b or c) have been studied with different techniques Recently, Kent-First et a l  (1996) suggested that the existence
and, thirdly, information on clinical characteristics, such as of mosaicism may explain the finding that two of 32 oligozoo-
semen parameters, hormone concentrations and andrological spermic men without microdeletions (tested by PCR analysis)
history, is scarce. fathered TCSI-sons’ with microdeletions. Thirdly, it is possible
For the majority of the men, ICSI is the last resort to obtain that in addition to the known deletions other unknown
offspring. There is discussion in the literature about the safety mutations in the AZF genes could be present. Finally, it may
of ICSI (Meschede et a l ,  1995). Although data about short- be expected that in the near future other spermatogenesis genes
term effects (e.g. major and minor congenital anomalies) are (and their mutations) will be discovered.
reassuring (Bonduelle et al., 1995), questions about genetic One could imagine that microdeletions of the Y chromosome
risks and long-term effects of ICSI remain to be answered. In will be transmitted to male offspring and that these sons will
the light of this discussion it is important to have more 
information on the prevalence of genetic defects in men 
undergoing ICSI and their clinical characteristics.
have a risk of having the same fertility problems. Recently, it 
has been shown that microdeletions are indeed transmitted to 
the male offspring via ICSI (Kent-First et a l ,  1996). However 
The percentages of abnormal karyotypes in the present study the expected fertility problems in the sons remain to be proven, 
(1.8% in oligozoospermic men and 10,5% in azoospermic since Vogt et a l  (1996) described a man with a microdeletion 
men) are comparable with data in the literature (Relief et a l ,  in the AZFc region who fathered a son with the same 
1984); as expected the most frequent abnormality was the deletion. Despite this uncertainty, we recommend screening 
Klinefelter syndrome. for microdeletions in the AZF region before ICSI, especially
The 4.3% prevalence of microdeletions in the AZFc region, in those men with severe oligozoospermia (or azoospermia),
in our diverse ICSI population, suggests that microdeletions 
in the Y chromosome are a major factor in ‘ICSI-mcn*. As 
expected, no microdcletions in normozoospermic men were 
found. Moreover, no deletions in the azoospermic group were 
found, probably because of the low number of azoospermic
normal FSH and normal clinical andrological findings. The 
individual man with a microdeletion should be counselled 
extensively. Subsequently, it is up to the couple to make the 
final decision about further treatment.
In conclusion, the results of the present study show that
men in this population and the relatively high proportion of microdeletions in the AZFc region are frequently found in 
those azoospermic men with clear cause of the azoospermia men with severe and unexplained oligozoospermia. This 
(8/19). So, these dala are not representative for all azoospermic finding has a great impact, because severe male infertility has 
men. The relatively low number of men with idiopathic non- now become a hereditary disorder that can be transmitted 
obstructive azoospermia in our population may also explain by ICSI. 
the absence of microdeletions in the AZFa and AZFb region 
in our study, since these deletions have been described mainly 
in non-obstructive azoospermia (Vogt et al., 1996).
Our data show that oligozoospermic men with microdele­
tions have significantly lower FSH and LI-1 concentrations in 
comparison with men without microdeletions. Furthermore, 
the I\SH and LH concentrations of men with microdeletions 
were comparable to those in normozoospermic men. This 
suggests that the endocrine system, in contrast with the 
spermalogenie system, is intact. Moreover, the fact that the 
ejaculates of men with microdeletions contain a significantly 
lower total number of motile spermatozoa, provides evidence 
for a severe spermatogenic defect. Finally, the presence of 
microdeletions is associated with the absence of abnormal 
findings at andrological history and examination: one in seven 
men with a mierodeleiion had a varicocele, a prevalence 
comparable with that in normozoospermic men. Using these 
clinical parameters, it is possible to define a subgroup of men 
who are at risk for having a microdeletion: in this study, men 
with severe oligozoospermia, normal FSH and normal clinical 
andrological findings have a risk of 20% of having microdele­
tions in the AZFc region, Because of the relatively low 
numbers, care must be taken with the extrapolation of these 
percentages to oligozoospermic men in general.
For several reasons it is tempting to speculate that the
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